RETRACTED: Knockdown PEG10 deteriorates H2O2-injury of PC-12 cells by targeting miR-34a-5p/TLX (Publication with Expression of Concern. See vol. 141, pg. 346, 2022) (Retracted article. See vol. 144, pg. 178, 2022)

被引:5
|
作者
Niu, Shizhen [1 ]
Ni, Yong [2 ]
Niu, Tong [2 ]
Gao, Jianwen [2 ]
机构
[1] Jining Med Univ, Sch Clin Med, 16 Hehua Rd, Jining 272067, Shandong, Peoples R China
[2] Jining 1 PeopleS Hosp, Dept Spine Surg, Jining 272011, Shandong, Peoples R China
关键词
Spinal cord injury; lncRNA PEG10; miR-34a-5p; TLX; Smad and Wnt/beta-catenin pathways; SPINAL-CORD-INJURY; EXPRESSION; TLX; GENE;
D O I
10.1016/j.molimm.2019.11.012
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Objective: Spinal cord injury (SCI) is a neurological disease with high incidence and disability. In this paper, we made a foundational study in long non-coding RNA paternally expressed gene 10 (lncRNA PEG10) at PC-12 cells. Methods: We used CCK8, flow cytometry, migration and invasion assay to detect changes at the cellular level. PEG10, microRNA-34a-5p (miR-34a-5p) and TLX transfected by transfection assay and amplified by real-time quantitative PCR (qRT-PCR). TLX expression and proteins about apoptosis and pathways were investigated by Western blot. Additionally, the relationship between PEG10 and miR-34a-5p, miR-34a-5p and TLX were examined through luciferase assay. Results: H2O2-injury model was established. Knockdown PEG10 deteriorated H2O2-injury. miR-34a-5p was confirmed as a target of PEG10 and miR-34a-5p inhibitor remitted PEG10-induced H2O2-injury. Moreover, TLX was confirmed as a target miR-34a-5p and TLX remitted H2O2-injury. At last, TLX worked in H2O2-injury via Smad and Wnt/beta-catenin pathways. Conclusion: Knockdown PEG10 remitted H2O2-injury of PC-12 cells by targeting miR-34a-5p/TLX, and the behavior may be involved in Smad and Wnt/beta-catenin pathways.
引用
收藏
页码:1 / 8
页数:8
相关论文
共 50 条
  • [1] RETRACTED: PHOX2B Is Associated with Neuroblastoma Cell Differentiation (Publication with Expression of Concern. See vol. 37, pg. 332, 2022) (Retracted article. See vol. 37, pg. 333, 2022)
    Yang, Liqun
    Ke, Xiao-Xue
    Xuan, Fan
    Tan, Juan
    Hou, Jianbing
    Wang, Mei
    Cui, Hongjuan
    Zhang, Yundong
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2016, 31 (02) : 44 - 51
  • [2] RETRACTED: miR-139-5p regulates proliferation, apoptosis, and cell cycle of uterine leiomyoma cells by targeting TPD52 (Publication with Expression of Concern. See vol. 13, pg. 6855, 2020) (Retracted article. See vol. 16, pg. 475, 2023)
    Chen, Hong
    Xu, Hong
    Meng, Yu-gang
    Zhang, Yun
    Chen, Jun-ying
    Wei, Xiao-ning
    ONCOTARGETS AND THERAPY, 2016, 9 : 6151 - 6160
  • [3] RETRACTED: Tub Has a Key Role in Insulin and Leptin Signaling and Action In Vivo in Hypothalamic Nuclei(Retracted article. See vol. 66, pg. 785, 2017) (Publication with Expression of Concern. See vol. 65, pg. 1121, 2016) (Retracted article. See vol. 66, pg. 785, 2017)
    Prada, Patricia O.
    Quaresma, Paula G. F.
    Caricilli, Andrea M.
    Santos, Andressa C.
    Guadagnini, Dioze
    Morari, Joseane
    Weissmann, Lais
    Ropelle, Eduardo R.
    Carvalheira, Jose Barreto C.
    Velloso, Licio A.
    Saad, Mario J. A.
    DIABETES, 2013, 62 (01) : 137 - 148
  • [4] RETRACTED: TRIF/miR-34a mediates aldosterone-induced cardiac inflammation and remodeling (Publication with Expression of Concern. See vol. 134, pg. 2053, 2020) (Retracted article. See vol. 135, pg. 229, 2021)
    Li, Shaojun
    Cao, Wei
    Wang, Bai
    Zhan, Enbo
    Xu, Jian
    Li, Shufeng
    CLINICAL SCIENCE, 2020, 134 (12) : 1319 - 1331
  • [5] RETRACTED: MicroRNA-217 acts as a tumor suppressor and correlates with the chemoresistance of cervical carcinoma to cisplatin (Publication with Expression of Concern. See vol. 15, pg. 841, 2022) (Retracted article. See vol. 16, pg. 471, 2023)
    Yin, Zhaojun
    Ren, Weiru
    ONCOTARGETS AND THERAPY, 2019, 12 : 759 - 771
  • [6] RETRACTED: miR-152-3p Sensitizes Glioblastoma Cells Towards Cisplatin Via Regulation Of SOS1 (Publication with Expression of Concern. See vol. 15, pg. 779, 2022) (Retracted article. See vol. 16, pg. 477, 2023)
    Wang, Meihua
    Wu, Qi
    Fang, Mingming
    Huang, Wu
    Zhu, Hong
    ONCOTARGETS AND THERAPY, 2019, 12 : 9513 - 9525
  • [7] RETRACTED: Knockdown of ANRIL aggravates H2O2-induced injury in PC-12 cells by targeting microRNA-125a (Retracted article. See vol. 148, 2022)
    Li, Ran
    Yin, Fei
    Guo, Ying-Ying
    Zhao, Kun-Chi
    Ruan, Qing
    Qi, Ying-Mei
    BIOMEDICINE & PHARMACOTHERAPY, 2017, 92 : 952 - 961
  • [8] RETRACTED: Targeting NEK2 attenuates glioblastoma growth and radioresistance by destabilizing histone methyltransferase EZH2 (Publication with Expression of Concern. See vol. 130, pg. 5027, 2020) (Retracted article. See vol. 130, pg. 6187, 2020)
    Wang, Jia
    Cheng, Peng
    Pavlyukov, Marat S.
    Yu, Hai
    Zhang, Zhuo
    Kim, Sung-Hak
    Minata, Mutsuko
    Mohyeldin, Ahmed
    Xie, Wanfu
    Chen, Dongquan
    Goidts, Violaine
    Frett, Brendan
    Hu, Wenhao
    Li, Hongyu
    Shin, Yong Jae
    Lee, Yeri
    Nam, Do-Hyun
    Kornblum, Harley I.
    Wang, Maode
    Nakano, Ichiro
    JOURNAL OF CLINICAL INVESTIGATION, 2017, 127 (08) : 3075 - 3089
  • [9] RETRACTED: LncRNA NOP14-AS1 Promotes Tongue Squamous Cell Carcinoma Progression by Targeting MicroRNA-665/HMGB3 Axis (Publication with Expression of Concern. See vol. 14, pg. 2311, 2022) (Retracted article. See vol. 14, pg. 2733, 2022)
    Li, Jiayi
    Fan, Shuxia
    Liu, Shuang
    Yang, Guang
    Jin, Qingsong
    Xiao, Zhen
    CANCER MANAGEMENT AND RESEARCH, 2021, 13 : 2821 - 2834
  • [10] RETRACTED: Targeting ceramide synthase 6-dependent metastasis-prone phenotype in lung cancer cells (Publication with Expression of Concern. See vol. 129, pg. 3464, 2019) (Retracted article. See vol. 129, pg. 5050, 2019)
    Suzuki, Motoshi
    Cao, Ke
    Kato, Selichi
    Komizu, Yuji
    Mizutani, Naold
    Tanaka, Kouji
    Arima, Chinatsu
    Tai, Mei Chee
    Yanagisawa, Kiyoshi
    Togawa, Norie
    Shiraishi, Takahiro
    Usami, Noriyasu
    Taniguchi, Tetsuo
    Fukui, Takayuki
    Yokoi, Kohei
    Wakahara, Keiko
    Hasegawa, Yoshinori
    Mizutani, Yukiko
    Igarashi, Yasuyuki
    Inokuchi, Jin-ichi
    Iwaki, Soichiro
    Fujii, Satoshi
    Satou, Akira
    Matsumoto, Yoko
    Ueoka, Ryuichi
    Tamiya-Koizumi, Keiko
    Murate, Takashi
    Nakamura, Mitsuhiro
    Kyogashima, Mamoru
    Takahashi, Takashi
    JOURNAL OF CLINICAL INVESTIGATION, 2016, 126 (01) : 254 - 265